Similar articles

• Mortality trend of hematologic and lymphatic malignancy (lymphoma, multiple myeloma and leukemia) in Japan: 1960-2000.

  Yoshimi I, Kaneko S. Yoshimi I, et al. Jpn J Clin Oncol. 2004 Apr;34(4):218-25. Jpn J Clin Oncol. 2004. PMID: 15190904 No abstract available.
• A descriptive epidemiological study of hematopoietic neoplasms in Japan.

  Kato I, Tajima K, Hirose K, Nakagawa N, Kuroishi T, Tominaga S. Kato I, et al. Jpn J Clin Oncol. 1985 Jun;15(2):347-64. Jpn J Clin Oncol. 1985. PMID: 4021118
• Mortality trends of hematologic neoplasms (lymphoma, myeloma, and leukemia) in Japan (1960-2000): with special reference to birth cohort.

  Yoshimi I, Mizuno S. Yoshimi I, et al. Jpn J Clin Oncol. 2004 Oct;34(10):634-7. doi: 10.1093/jjco/hyh114. Jpn J Clin Oncol. 2004. PMID: 15591464 No abstract available.
• Racial differences in the incidence and outcomes for patients with hematological malignancies.

  Flowers CR, Glover R, Lonial S, Brawley OW. Flowers CR, et al. Curr Probl Cancer. 2007 May-Jun;31(3):182-201. doi: 10.1016/j.currproblcancer.2007.01.005. Curr Probl Cancer. 2007. PMID: 17543947 Review. No abstract available.
• [Epidemiology of lymphoid and hematopoietic malignancies in Japan].

  Tajima K, Hirose K. Tajima K, et al. Gan To Kagaku Ryoho. 2001 Feb;28(2):189-94. Gan To Kagaku Ryoho. 2001. PMID: 11242645 Review. Japanese.